← Back to Clinical Trials
Recruiting NCT05771168

NCT05771168 Surgery for Male Stress Urinary Incontinence

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05771168
Status Recruiting
Phase
Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Condition Male Stress Urinary Incontinence
Study Type OBSERVATIONAL
Enrollment 138 participants
Start Date 2022-09-29
Primary Completion 2027-09-29

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Artificial urinary sphincterMale sling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 138 participants in total. It began in 2022-09-29 with a primary completion date of 2027-09-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this observational prospective study is to evaluate the success rate (cure plus improvement) of procedures for treatment of male stress urinary incontinence (artificial urinary sphincter or male slings) at 5 years of study follow-up and to determine other outcomes of surgical treatment for each of the devices and, to perform a prognostic factor analysis to identify clinical and surgical variables that correlate with (in)continence or revisions for each of the device subtypes. Cure is defined as urinary continence with no need for use of pads or the use of 1 light security pad; the improvement is defined as the reduction of≥ 50% of the number of pads with use of no more than two pads.

Eligibility Criteria

Inclusion Criteria: * Male patients undergoing surgery for stress incontinence using medical devices such as AUS or sling * Participant is willing and able to complete the questionnaires and give informed consent for participation in the study Exclusion Criteria: \- Participant unable to complete the questionnaires and declining informed consent for participation in the study

Contact & Investigator

Central Contact

Emilio Sacco, Professor

✉ emilio.sacco@policlinicogemelli.it

📞 +390630155290

Frequently Asked Questions

Who can join the NCT05771168 clinical trial?

This trial is open to male participants only, aged 18 Years or older, studying Male Stress Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05771168 currently recruiting?

Yes, NCT05771168 is actively recruiting participants. Contact the research team at emilio.sacco@policlinicogemelli.it for enrollment information.

Where is the NCT05771168 trial being conducted?

This trial is being conducted at Roma, Italy.

Who is sponsoring the NCT05771168 clinical trial?

NCT05771168 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 138 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology